The fibromyalgia syndrome: translating science into clinical practice

Journal of Musculoskeletal Pain

Volumn 17, Issue 2, 2009, Pages 189-194

  Henriksson, Karl G ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Central sensitization; Fibromyalgia syndrome; Muscle pain

Indexed keywords

ADRENERGIC SYSTEM; ALLODYNIA; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLINICAL PRACTICE; COGNITION; DIAGNOSTIC TEST; DYNAMIC EXERCISE; EMOTION; FATIGUE; FIBROMYALGIA; GLIA CELL; HEREDITY; HUMAN; HYPERALGESIA; HYPERSENSITIVITY; MICROCIRCULATION; MUSCLE BLOOD FLOW; MUSCLE ISCHEMIA; MUSCLE METABOLISM; MYALGIA; NERVE CELL STIMULATION; NEUROMODULATION; NEUROTRANSMISSION; NOCICEPTION; NOCICEPTIVE RECEPTOR; NOCICEPTIVE STIMULATION; PAIN; PAIN ASSESSMENT; PAIN THRESHOLD; PALPATION; PERIPHERAL NERVOUS SYSTEM; PSYCHOLOGICAL ASPECT; RELIABILITY; REVIEW; RISK FACTOR; SENSITIZATION; SENSORY SYSTEM; SLEEP DISORDER; STATIC EXERCISE; TRIGGER POINT;

EID: 67649647734     PISSN: 10582452     EISSN: 15407012     Source Type: Journal    
DOI: 10.1080/10582450902816539     Document Type: Review

References (47)

1. Mense S: The pathogenesis of muscle pain. Curr Pain Headache Rep 7: 419-425, 2003.
2. Bennett R: Fibromyalgia: Present to future. Curr Pain Headache Rep 8: 379-384, 2004.
3. Woolf CJ, Salter MW: Plasticity and pain: role of the dorsal horn. Textbook of pain. Edited by SB Mc Mahon, M Koltzenburg. Elsevier Churchill Livingstone, Philadelphia, 2006, pp. 91-105.
4. Bengtsson A, Henriksson KG, Jorfeldt L, Kågedal B, Lennmarken C, Lindström F: Primary fibromyalgia. A clinical and laboratory study of 55 patients. Scand J Rheumatol 15: 340-347, 1986.
5. Henriksson C, Carlberg U, Kjällman M, Lund berg G, Henriksson KG: Evaluation of four outpatient educational programmes for patients with longstanding fibromyalgia. J Rehabil Med 36: 211-219, 2004.
6. Clauw DJ, Paul P: The overlap between fibromyalgia and inflammatory rheumatic diseases: when and why does it occur? Clin Rheumatol 1: 335-341, 1995.
7. Delorme T, Boureau F, Eymard B, Laforet P, Cot- trel F: Clinical study of chronic pain in hereditary myopathies. Eur J Pain 8: 55-61, 2004.
8. Bengtsson A, Editorial: The muscle in fibromyalgia. Rheumatol 41: 721-724, 2002.
9. Sprott H: Muscles and peripheral abnormalities in fibromyalgia: Fibromyalgia & other central pain syndromes. Lippincott Williams & Wilkins, Philadelphia, 2005, pp. 101-113.
10. Elvin A, Siösteen A-K, Nilsson A, Kosek E: Decreased muscle blood flow in fibromyalgia patients during standardised muscle exercise: A contrast media enhanced colour doppler study. Eur J Pain 10: 137-144, 2006.
11. Moldofsky H, MacFarlane JG: Sleep and its potential role in chronic pain and fatigue: Fibromyalgia & other central pain syndromes. Lippincott Williams & Wilkins, Philadelphia, 2005, pp. 115-124.
12. Russell IJ, Bieber CS: Myofascial pain and fibromyalgia syndrome. Textbook of pain. Edited by SB McMahon, M Koltzenburg. Elsevier Churchill Livingstone, Philadelphia, 2006, pp. 669-681.
13. Martinez-Lavin M: Dysfunction of the autonomic nervous system in chronic pain syndromes: Fibromyalgia & other central pain syndromes. Lippincott Williams & Wilkins, Philadelphia, 2005, pp. 81-87.
14. McEwen BS: Protective and damaging effects of stress mediators. N Engl J Med 3: 171-179, 1998.
15. Watkins LR, Milligan ED, Maier SF: Glial activation: a driving force for pathological pain. Trends Neurosci 24(8): 450-455, 2001.
16. Bartfai T: Telling the brain about pain. Nature 410: 425-427, 2001.
17. Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, et al.: Interleukin - lfi- mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471-475, 2001.
18. Ek M, Engblom D, Saha S, Blomqvist A, Jakobsson P-J, Ericsson-Dahlstrand A: Pathway across the blood-brain barrier. Nature 410: 430-431, 2001.
19. Wallace DJ, Linker-Israeli M, Hallegua D, Silverman S, Silver D, Weisman MH: Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumatology 40: 743-749, 2001.
20. Buskila D, Neumann L, Press J: Genetic factors in neuromuscular pain. CNS Spectr 10: 281-284, 2005.
21. Maquet D, Croisier J-L, Demoulin Ch, Crielaard J-M: Pressure pain thresholds of tender point sites in patients with fibromyalgia and in healthy controls. Eur J Pain 8: 111-117, 2004.
22. Chesterton LS, Barlas P, Foster NE, Baxter GD, Wright CC: Gender differences in pressure pain threshold in healthy humans. Pain 101: 259-266, 2003.
23. Jones AKP: The role of the cerebral cortex in pain perception. Pain 2005 - An Updated Review: Refresher Course Syllabus. Edited by Douglas M Justins, IASP Press, Seattle, 2005, p 59-68.
24. Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, et al.: Subgrouping of fibromyalgia patients on the basis of pressure-pain thresholds and psychological factors. Arthritis Rheum 48: 2916-2922, 2003.
25. Henriksson C: Living with fibromyalgia. A study of the consequences for daily activities. Linköping University Medical Dissertation No 445 Sweden: ISBN 91- 7871-297-1,1995.
26. Henriksson C, Liedberg G: Factors of importance for work disability in women with fibromyalgia. J Rheumatol 27: 1271-1276, 2000.
27. Petzke F, Clauw DJ, Ambrose K, Khine A, Gracely RH: Increased pain sensitivity in fibromyalgia: effects of stimulus type and mode of presentation. Pain 109: 524-525, 2004.
28. Henriksson KG: Fibromyalgia - from syndrome to disease. Overview of pathogenetic mechanisms. J Rehabil Med (suppl 41): 89-94, 2003.
29. Yunus MB: The concept of central sensitivity syndromes: Fibromyalgia & other central pain syndromes. Lippincott Williams & Wilkins, Philadelphia, 2005, pp. 29-44.
30. Sörensen J, Bengtsson A, Bäckman E, Henriksson KG, Bengtsson M: Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine and ketamine. Scand J Rheumatol 24: 360-365, 1995.
31. Graven-Nielsen T, Aspegren Kendall S, Henriksson KG, Bengtsson M, Sörensen J, Johnson A, et al.: Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients. Pain 85:483-491, 2000.
32. Staud R, Cannon RC, Mauderli AP, Robinson ME, Price DD, Vierck Jr CJ: Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 102: 87-95, 2003.
33. Arroyo JF, Cohen ML: Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 10: 1925-1931,1993.
34. Vecchiet L, Giamberardino MA, de Bigontina P, Dragani L: Comparative sensory evaluation of parietal tissues in painful and nonpainful areas in fibromyalgia and myofascial pain syndrome. Edited by GF Gebhart, DL Hammond, TS Jensen: Progress in Pain Research and Management. IASP Press, Seattle, 1994:2: pp. 177- 185.
35. Banic B, Petersen-Felix S, Andersen OK, Radanov BP, Villiger PM, Arendt-Nielsen L, et al.: Evidence for spinal cord hypersensitivity in chronic pain after whiplash injury and in fibromyalgia. Pain 107: 7- 15, 2004.
36. Bengtsson M, Bengtsson A, Jorfeldt L: Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise. Pain 29: 171-180, 1989.
37. Gracely RH, Petzke F, Wolf JM, Clauw DJ: Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46: 1333-1343, 2002.
38. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, et al.: Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arhtritis Rheum 38: 926-938, 1995.
39. Bendtsen L, Norregaard J, Jensen R, Olesen J: Evidence of qualitatively altered nociception in patients with fibromyalgia. Arthritis Rheum 40: 98-102,1997.
40. 2 laser stimulation in subjects with fibromyalgia syndrome. Pain 58: 185-193, 1994.
41. Lorentz J, Grasedyck K, Bromm B: Middle and long latency somatosensory evoked potentials after painful laser stimulation in patients with fibromyalgia syndrome. Electroencephal Clin Neurophysiol 100: 165-168,1996.
42. Kosek K, Ekholm J, Hansson P: Modulation of pressure pain thresholds during and following isometric contraction in patients with fibromyalgia and in healthy controls. Pain: 64: 415-123, 1996.
43. Staud R, Robinson ME, Price DD: Isometric exercise has opposite effects on central pain mechanisms in fibromyalgia patients compared to normal controls. Pain 118: 176-184,2005.
44. Kosek E, Hansson P: Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 70: 41-51, 1997.
45. Staud R, Robinson ME, Vierck CJ, Price DD: Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 101: 167-174, 2003.
46. Kosek E, Ekholm J, Hansson P: Sensory dysfunction in fibromyalgia patient with implications for pathogenic mechanisms. Pain 68: 375-383,1996.
47. Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al.: Elevated cerebrospinal levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 37: 1593-1601,1994.